Regulation of immune responses by CD1d-restricted natural killer T cells

被引:59
作者
Van Kaer, L [1 ]
机构
[1] Vanderbilt Univ, Sch Med, Med Ctr N, Dept Microbiol & Immunol, Nashville, TN 37232 USA
关键词
alpha-galactosylceramide; antigen presentation; autoimmunity; experimental autoimmune encephalomyelitis; CD1d; glycolipids; immunomodulation; immunotherapy; natural killer T cells; type; 1; diabetes;
D O I
10.1385/IR:30:2:139
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Natural killer T (NKT) cells area unique subset of T lymphocytes that share receptor structures and properties with conventional T lymphocytes and natural killer (NK) cells. NKT cells are specific for glycolipid antigens such as the marine sponge-derived agent alpha-galactosylceramide (alpha-GalCer) presented by the major histocompatibility complex (MHC) class I-like molecule CD1d. My laboratory has evaluated the function of NKT cells by generating and analyzing CD1d-deficient mice. These studies showed that CD1d expression is required for NKT cell development, but not absolutely necessary for the generation of polarized T helper (Th) cell responses. Further, we have studied the in vivo response of NKT cells to alpha-GalCer stimulation and the capacity of alpha-GalCer to modulate innate and adaptive immune responses. Our results revealed that, quickly following administration of alpha-GalCer, NKT cells expand and produce cytokines. trans-activate a variety of innate and adaptive immune cells. and promote Th2 responses that are capable of suppressing Th1-dominant autoimmunity. Our findings indicate that NKT cells play a regulatory role in the immune response and that specific activation of these cells may be exploited for therapeutic purposes.
引用
收藏
页码:139 / 153
页数:15
相关论文
共 75 条
[1]   The NOD mouse model of type 1 diabetes: As good as it gets? [J].
Atkinson, MA ;
Leiter, EH .
NATURE MEDICINE, 1999, 5 (06) :601-604
[2]   Tolerance to islet autoantigens in type 1 diabetes [J].
Bach, JF ;
Chatenoud, L .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :131-161
[3]   Mouse CD1-specific NK1 T cells: Development, specificity, and function [J].
Bendelac, A ;
Rivera, MN ;
Park, SH ;
Roark, JH .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :535-562
[4]   A SUBSET OF CD4(+) THYMOCYTES SELECTED BY MHC CLASS-I MOLECULES [J].
BENDELAC, A ;
KILLEEN, N ;
LITTMAN, DR ;
SCHWARTZ, RH .
SCIENCE, 1994, 263 (5154) :1774-1778
[5]   CD1 RECOGNITION BY MOUSE NK1(+) T-LYMPHOCYTES [J].
BENDELAC, A ;
LANTZ, O ;
QUIMBY, ME ;
YEWDELL, JW ;
BENNINK, JR ;
BRUTKIEWICZ, RR .
SCIENCE, 1995, 268 (5212) :863-865
[6]   In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers [J].
Benlagha, K ;
Weiss, A ;
Beavis, A ;
Teyton, L ;
Bendelac, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (11) :1895-1903
[7]   CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution [J].
Brossay, L ;
Chioda, M ;
Burdin, N ;
Koezuka, Y ;
Casorati, G ;
Dellabona, P ;
Kronenberg, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (08) :1521-1528
[8]  
Burdin N, 1999, EUR J IMMUNOL, V29, P2014, DOI 10.1002/(SICI)1521-4141(199906)29:06<2014::AID-IMMU2014>3.0.CO
[9]  
2-G
[10]   The paradox of immune molecular recognition of α-galactosylceramide:: Low affinity, low specificity for CD1d, high affinity for αβ TCRs [J].
Cantu, C ;
Benlagha, K ;
Savage, PB ;
Bendelac, A ;
Teyton, L .
JOURNAL OF IMMUNOLOGY, 2003, 170 (09) :4673-4682